Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Anthracycline drug targeting: cytoplasmic versus nuclear--a fork in the road.
- L. Lothstein, M. Israel, T. Sweatman
- Biology, ChemistryDrug resistance updates : reviews and…
- 1 June 2001
TLDR
Clinical evaluation of long-term, continuous-infusion doxorubicin.
- M. Garnick, G. R. Weiss, E. Frei
- MedicineCancer treatment reports
- 1 February 1983
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
- A. Bodley, L. Liu, M. Potměšil
- Chemistry, BiologyCancer research
- 1 November 1989
TLDR
N-benzyladriamycin-14-valerate (AD 198) activates protein kinase C-δ holoenzyme to trigger mitochondrial depolarization and cytochrome c release independently of permeability transition pore opening…
- L. Lothstein, L. Savranskaya, C. Barrett, M. Israel, T. Sweatman
- Biology, ChemistryAnti-cancer drugs
- 1 June 2006
TLDR
Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge.
- T. Lampidis, D. Kolonias, W. Priebe
- Biology, ChemistryBiochemistry
- 4 March 1997
TLDR
ATM and the Catalytic Subunit of DNA-Dependent Protein Kinase Activate NF-κB through a Common MEK/Extracellular Signal-Regulated Kinase/p90rsk Signaling Pathway in Response to Distinct Forms of DNA…
TLDR
Metabolism and elimination of rhodamine 123 in the rat
- T. Sweatman, R. Seshadri, M. Israel
- Biology, MedicineCancer Chemotherapy and Pharmacology
- 2004
TLDR
Novel extranuclear-targeted anthracyclines override the antiapoptotic functions of Bcl-2 and target protein kinase C pathways to induce apoptosis.
- C. Barrett, Felicia L. Lewis, L. Lothstein
- Biology, ChemistryMolecular cancer therapeutics
- 1 May 2002
TLDR
Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation…
- J. Roaten, M. Kazanietz, T. Sweatman
- Biology, ChemistryMolecular cancer therapeutics
- 1 May 2002
Anthracycline antibiotics like doxorubicin (DOX) are known to exert their antitumor effects primarily via DNA intercalation and topoisomerase II inhibition. By contrast, the noncross-resistant…
Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells.
- M. Levin, R. Silber, M. Israel, A. Goldfeder, V. Khetarpal, M. Potměšil
- Chemistry, BiologyCancer research
- 1 March 1981
TLDR
...
...